An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-05-16
- Last Posted Date
- 2014-05-12
- Lead Sponsor
- Cougar Biotechnology, Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT00474383
A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-05-15
- Last Posted Date
- 2014-03-27
- Lead Sponsor
- Cougar Biotechnology, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT00473512
© Copyright 2024. All Rights Reserved by MedPath